Prognostic Significance of Endoglin (CD105) as an Angiogenic Marker in Endocervical Adenocarcinoma

被引：0
|
作者：
Cullen, E.
Silverman, J. F.
Khalifa, M. A.
Ismiil, N.
Dube, V.
Nofech-Mozes, S.
Ghorab, Z.
Saad, R. S.
机构：
[1] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[2] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1068
引用
收藏
页码：239A / 239A
页数：1
相关论文
共 50 条
  • [1] Prognostic Significance of Endoglin (CD105) as an Angiogenic Marker in Endocervical Adenocarcinoma
    Cullen, E.
    Silverman, J. F.
    Khalifa, M. A.
    Ismiil, N.
    Dube, V.
    Nofech-Mozes, S.
    Ghorab, Z.
    Saad, R. S.
    LABORATORY INVESTIGATION, 2010, 90 : 239A - 239A
  • [2] Prognostic Significance of Endoglin (CD105) as Angiogenic Marker in Endometrial Carcinosarcoma
    Uihlein, A.
    Ismiil, N.
    Nofech-Mozes, S.
    Khalifa, M. A.
    Silverman, J. F.
    Dube, V.
    Saad, R. S.
    LABORATORY INVESTIGATION, 2009, 89 : 239A - 239A
  • [3] Prognostic Significance of Endoglin (CD105) as Angiogenic Marker in Endometrial Carcinosarcoma
    Uihlein, A.
    Ismiil, N.
    Nofech-Mozes, S.
    Khalifa, M. A.
    Silverman, J. F.
    Dube, V.
    Saad, R. S.
    MODERN PATHOLOGY, 2009, 22 : 239A - 239A
  • [4] Clinical significance of Leptin receptor (LEPR) and Endoglin (CD105) expressions in colorectal adenocarcinoma
    Vuletic, Milena S.
    Milosevic, Velimir S.
    Jancic, Snezana A.
    Zujovic, Janko T.
    Krstic, Miljan S.
    Vukmirovic, Filip C.
    JOURNAL OF BUON, 2019, 24 (06): : 2448 - 2457
  • [5] CD105 (Endoglin) as negative prognostic factor in AML
    Joseph Kauer
    Karolin Schwartz
    Claudia Tandler
    Clemens Hinterleitner
    Malte Roerden
    Gundram Jung
    Helmut R. Salih
    Jonas S. Heitmann
    Melanie Märklin
    Scientific Reports, 9
  • [6] CD105 (Endoglin) as negative prognostic factor in AML
    Kauer, Joseph
    Schwartz, Karolin
    Tandler, Claudia
    Hinterleitner, Clemens
    Roerden, Malte
    Jung, Gundram
    Salih, Helmut R.
    Heitmann, Jonas S.
    Maerklin, Melanie
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [7] Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma
    El-Gohary, Yasser M.
    Silverman, Jan F.
    Olson, Peter R.
    Liu, Yulin L.
    Cohen, Jeffrey K.
    Miller, Ralph
    Saad, Reda S.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 127 (04) : 572 - 579
  • [8] Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma
    Saad, RS
    El-Gohary, Y
    Memari, E
    Liu, YL
    Silverman, JF
    HUMAN PATHOLOGY, 2005, 36 (09) : 955 - 961
  • [9] Expression of endoglin (CD105) in hepatocellular carcinoma with its clinicopathological and prognostic significance analysis
    Lin, Ming-Tsung
    Yen, Yi-Hao
    Tseng, Po-Lin
    Chang, Kuo-Chin
    Hu, Tsung-Hui
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 336 - 336
  • [10] Endoglin (CD105) as a urinary and serum marker of prostate cancer
    Fujita, Kazutoshi
    Ewing, Charles M.
    Chan, David Y. S.
    Mangold, Leslie A.
    Partin, Alan W.
    Isaacs, William B.
    Pavlovich, Christian P.
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (03) : 664 - 669
12345